Phase II Study of Dovitinib in Patients with Castration-Resistant Prostate Cancer (KCSG-GU11-05)
Yoon Ji Choi, Hye Sook Kim, Se Hoon Park, Bong-Seog Kim, Kyoung Ha Kim, Hyo Jin Lee, Hong Suk Song, Dong-Yeop Shin, Ha Young Lee, Hoon-Gu Kim, Kyung Hee Lee, Jae Lyun Lee, Kyong Hwa Park
Cancer Res Treat. 2018;50(4):1252-1259.   Published online 2018 Jan 2     DOI: https://doi.org/10.4143/crt.2017.438
Citations to this article as recorded by Crossref logo
Comprehensive Review on Recent Strategies for Management of Prostate Cancer: Therapeutic Targets and SAR
Manish Chaudhary, Shubham Kumar, Paranjeet Kaur, Sanjeev Kumar Sahu, Amit Mittal
Mini-Reviews in Medicinal Chemistry.2024; 24(7): 721.     CrossRef
Role of Basic Fibroblast Growth Factor in Cancer: Biological Activity, Targeted Therapies, and Prognostic Value
Alessio Ardizzone, Valentina Bova, Giovanna Casili, Alberto Repici, Marika Lanza, Raffaella Giuffrida, Cristina Colarossi, Marzia Mare, Salvatore Cuzzocrea, Emanuela Esposito, Irene Paterniti
Cells.2023; 12(7): 1002.     CrossRef
Case Report of a Glioma Patient with Homozygous Missense Amino Acid Substitution in KDR Gene
Kalyan Ram Uppaluri, Himavanth Reddy Kambalachenu, Hima Jyothi Challa, Saadvik Raghuram Y., Deepak Sharma, Ramya Gadicherla, Srinivas Ketavath, Kalyani Palasamudram, Sri Manjari K.
Indian Journal of Medical and Paediatric Oncology.2023; 44(03): 356.     CrossRef
FGFR families: biological functions and therapeutic interventions in tumors
Qing Liu, Jiyu Huang, Weiwei Yan, Zhen Liu, Shu Liu, Weiyi Fang
MedComm.2023;[Epub]     CrossRef
Targeting transforming growth factor‐ß signalling for cancer prevention and intervention: Recent advances in developing small molecules of natural origin
Devesh Tewari, Anu Priya, Anusha Bishayee, Anupam Bishayee
Clinical and Translational Medicine.2022;[Epub]     CrossRef
Evaluation of the therapeutic potential of masitinib and expression of its specific targets c‐Kit, PDGFR‐α, PDGFR‐β, and Lyn in canine prostate cancer cell lines
Katharina Klose, Eva‐Maria Packeiser, José‐Luis Granados‐Soler, Marion Hewicker‐Trautwein, Hugo Murua Escobar, Ingo Nolte
Veterinary and Comparative Oncology.2022; 20(3): 641.     CrossRef
Phase 2 Study of Neoadjuvant FGFR Inhibition and Androgen Deprivation Therapy Prior to Prostatectomy
Elizabeth Liow, Nicholas Howard, Chol-Hee Jung, Bernard Pope, Bethany K. Campbell, Anne Nguyen, Michael Kerger, Jonathan B. Ruddle, Angelyn Anton, Benjamin Thomas, Kevin Chu, Philip Dundee, Justin S. Peters, Anthony J. Costello, Andrew S. Ryan, Christophe
Clinical Genitourinary Cancer.2022; 20(5): 452.     CrossRef
There are gremlins in prostate cancer
Laura A. Sena, W. Nathaniel Brennen, John T. Isaacs
Nature Cancer.2022; 3(5): 530.     CrossRef
Targeting signaling pathways in prostate cancer: mechanisms and clinical trials
Yundong He, Weidong Xu, Yu-Tian Xiao, Haojie Huang, Di Gu, Shancheng Ren
Signal Transduction and Targeted Therapy.2022;[Epub]     CrossRef
Concept of Hybrid Drugs and Recent Advancements in Anticancer Hybrids
Ankit Kumar Singh, Adarsh Kumar, Harshwardhan Singh, Pankaj Sonawane, Harshali Paliwal, Suresh Thareja, Prateek Pathak, Maria Grishina, Mariusz Jaremko, Abdul-Hamid Emwas, Jagat Pal Yadav, Amita Verma, Habibullah Khalilullah, Pradeep Kumar
Pharmaceuticals.2022; 15(9): 1071.     CrossRef
The FGF/FGFR system in the physiopathology of the prostate gland
Arianna Giacomini, Elisabetta Grillo, Sara Rezzola, Domenico Ribatti, Marco Rusnati, Roberto Ronca, Marco Presta
Physiological Reviews.2021; 101(2): 569.     CrossRef
Signaling Pathways That Control Apoptosis in Prostate Cancer
Amaal Ali, George Kulik
Cancers.2021; 13(5): 937.     CrossRef
A Review of the Pathophysiological Mechanisms Underlying Castration-resistant Prostate Cancer
Fionnuala Crowley, Michelle Sterpi, Conor Buckley, Lauren Margetich, Shivani Handa, Zach Dovey
Research and Reports in Urology.2021; Volume 13: 457.     CrossRef
Neoadjuvant Treatment with Angiogenesis-Inhibitor Dovitinib Prior to Local Therapy in Hepatocellular Carcinoma: A Phase II Study
F.J. Sherida H. Woei-A-Jin, Nir I. Weijl, Mark C. Burgmans, Arantza Fariña Sarasqueta, J. Tom van Wezel, Martin N.J.M. Wasser, Minneke J. Coenraad, Jacobus Burggraaf, Susanne Osanto
The Oncologist.2021; 26(10): 854.     CrossRef
Reprogramming of Protein-Targeted Small-Molecule Medicines to RNA by Ribonuclease Recruitment
Peiyuan Zhang, Xiaohui Liu, Daniel Abegg, Toru Tanaka, Yuquan Tong, Raphael I. Benhamou, Jared Baisden, Gogce Crynen, Samantha M. Meyer, Michael D. Cameron, Arnab K. Chatterjee, Alexander Adibekian, Jessica L. Childs-Disney, Matthew D. Disney
Journal of the American Chemical Society.2021; 143(33): 13044.     CrossRef
Bone microenvironment signaling of cancer stem cells as a therapeutic target in metastatic prostate cancer
Clara H. Lee, Ann M. Decker, Frank C. Cackowski, Russell S. Taichman
Cell Biology and Toxicology.2020; 36(2): 115.     CrossRef
Brivanib, a multitargeted small‐molecule tyrosine kinase inhibitor, suppresses laser‐induced CNV in a mouse model of neovascular AMD
Lele Li, Manhui Zhu, Wenli Wu, Bai Qin, Jiayi Gu, Yuanyuan Tu, Jianing Chen, Dong Liu, Yunwei Shi, Xiaojuan Liu, Aimin Sang, Dongmei Ding
Journal of Cellular Physiology.2020; 235(2): 1259.     CrossRef
In Vitro Effect of Dovitinib (TKI258), a Multi-Target Angiokinase Inhibitor on Aggressive Meningioma Cells
Arabinda Das, Jaime L. Martinez Santos, Mohammed Alshareef, Guilherme Bastos Ferreira Porto, Libby Kosnik Infinger, William A. Vandergrift, Scott M. Lindhorst, Abhay K. Varma, Sunil J. Patel, David Cachia
Cancer Investigation.2020; 38(6): 349.     CrossRef
Potential Role of Targeting KDR and Proteasome Inhibitors in the Therapy of Esophageal Squamous Cell Carcinoma
Ling Zhang, Xia Niu, Yanghui Bi, Heyang Cui, Hongyi Li, Xiaolong Cheng
Technology in Cancer Research & Treatment.2020; 19: 153303382094806.     CrossRef

Novel Therapeutic Strategies for CDK4/6 Inhibitors in Metastatic Castrate-Resistant Prostate Cancer

Adam M. Kase, John A. Copland, Winston Tan
OncoTargets and Therapy.2020; Volume 13: 10499.     CrossRef
Therapeutic implications of fibroblast growth factor receptor inhibitors in a combination regimen for solid tumors (Review)
Hong Luo, Tao Zhang, Peng Cheng, Dong Li, Oleksandr Ogorodniitchouk, Chaimaa Lahmamssi, Ge Wang, Meiling Lan
Oncology Letters.2020; 20(3): 2525.     CrossRef
Dovitinib Triggers Apoptosis and Autophagic Cell Death by Targeting SHP-1/p-STAT3 Signaling in Human Breast Cancers
Yi-Han Chiu, Yi-Yen Lee, Kuo-Chin Huang, Cheng-Chi Liu, Chen-Si Lin
Journal of Oncology.2019; 2019: 1.     CrossRef
Tumour-stroma ratio and 5-year mortality in gastric adenocarcinoma: a systematic review and meta-analysis
Niko Kemi, Maarit Eskuri, Joonas H. Kauppila
Scientific Reports.2019;[Epub]     CrossRef
Investigational fibroblast growth factor receptor 2 antagonists in early phase clinical trials to treat solid tumors
Dan Wang, Li Yang, Weina Yu, Yi Zhang
Expert Opinion on Investigational Drugs.2019; 28(10): 903.     CrossRef
A Novel FGFR3 Splice Variant Preferentially Expressed in African American Prostate Cancer Drives Aggressive Phenotypes and Docetaxel Resistance
Jacqueline Olender, Bi-Dar Wang, Travers Ching, Lana X. Garmire, Kaitlin Garofano, Youngmi Ji, Tessa Knox, Patricia Latham, Kenneth Nguyen, Johng Rhim, Norman H. Lee
Molecular Cancer Research.2019; 17(10): 2115.     CrossRef
Recent Advances in Prostate Cancer Treatment and Drug Discovery
Ekaterina Nevedomskaya, Simon Baumgart, Bernard Haendler
International Journal of Molecular Sciences.2018; 19(5): 1359.     CrossRef